Literature DB >> 1498339

Shear rate-dependent impairment of thrombus growth on collagen in nonanticoagulated blood from patients with von Willebrand disease and hemophilia A.

E Fressinaud1, K S Sakariassen, C Rothschild, H R Baumgartner, D Meyer.   

Abstract

Thrombus formation on collagen fibrils was quantified at venous (100/s) and arterial (650/s and 2,600/s) wall shear rates in blood from patients with various subtypes of von Willebrand disease (vWD) and with hemophilia A (HA). Nonanticoagulated blood was drawn directly from an antecubital vein over purified type III collagen fibrils exposed in parallel-plate perfusion chambers. Blood-collagen interactions were differentiated and quantified by morphometry as platelet adhesion, thrombus height, thrombus volume, and deposition of fibrin strands. Sixteen patients with vWD, including four type III, six type I, four type IIA, and two type IIB, were compared with 26 normal subjects and nine patients with HA, including six severe HA and three mild HA. Platelet adhesion and thrombus formation at 2,600/s were significantly decreased in blood from patients with vWD type III, IIA, and IIB, but not in blood from patients with type I and in HA. The abnormal thrombus formation was apparently not related to the decreased levels of factor VIII (F.VIII), because thrombus height and volume were normal in severe and mild HA. Thrombus formation at 650/s was also significantly decreased in patients with vWD type III, IIA, and IIB and slightly reduced in type I. Significant reduction in thrombus volume and height was also observed in blood from patients with severe HA, but not in mild HA. Thrombus dimensions were not affected at 100/s in the vWD subtypes. However, significantly decreased thrombus height and virtually absent fibrin deposition were observed in blood from patients with severe HA. Apparently, F.VIII supports thrombus formation at low and intermediate shear conditions, presumably through the generation of thrombin. In contrast, von Willebrand factor (vWF) mediates not only platelet adhesion, but also thrombus formation at intermediate and high shear rates. Thus, the relative contribution of coagulation (F.VIII) and platelet function (vWF) in thrombus formation appears to be shear rate dependent, but having optimal effects at different shear conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1498339

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Flow chamber and microfluidic approaches for measuring thrombus formation in genetic bleeding disorders.

Authors:  Rogier M Schoeman; Marcus Lehmann; Keith B Neeves
Journal:  Platelets       Date:  2017-05-22       Impact factor: 3.862

2.  Recombinant factor VIIa addition to haemophilic blood perfused over collagen/tissue factor can sufficiently bypass the factor IXa/VIIIa defect to rescue fibrin generation.

Authors:  R Li; K A Panckeri; P F Fogarty; A Cuker; S L Diamond
Journal:  Haemophilia       Date:  2017-05-05       Impact factor: 4.287

3.  Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system.

Authors:  Yuto Nakajima; Keiji Nogami; Koji Yada; Takeshi Kawamura; Kenichi Ogiwara; Shoko Furukawa; Naruto Shimonishi; Masahiro Takeyama; Midori Shima
Journal:  Int J Hematol       Date:  2019-11-18       Impact factor: 2.490

4.  Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site.

Authors:  Vishal Trivedi; Adrienne Boire; Boris Tchernychev; Nicole C Kaneider; Andrew J Leger; Katie O'Callaghan; Lidija Covic; Athan Kuliopulos
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

5.  Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels.

Authors:  M Lehmann; K Ashworth; M Manco-Johnson; J Di Paola; K B Neeves; C J Ng
Journal:  J Thromb Haemost       Date:  2017-11-23       Impact factor: 5.824

Review 6.  Matrix metalloproteases and PAR1 activation.

Authors:  Karyn M Austin; Lidija Covic; Athan Kuliopulos
Journal:  Blood       Date:  2012-10-18       Impact factor: 22.113

7.  Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs.

Authors:  Gillian Stephens; Ming He; Connie Wong; Marzena Jurek; Hans-Christian Luedemann; Golnaz Shapurian; Kevin Munnelly; Craig Muir; Pamela B Conley; David R Phillips; Patrick Andre
Journal:  Thromb J       Date:  2012-08-01

8.  Characterization of collagen thin films for von Willebrand factor binding and platelet adhesion.

Authors:  Ryan R Hansen; Alena A Tipnis; Tara C White-Adams; Jorge A Di Paola; Keith B Neeves
Journal:  Langmuir       Date:  2011-10-19       Impact factor: 4.331

9.  The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models.

Authors:  Abimbola A Onasoga-Jarvis; Karin Leiderman; Aaron L Fogelson; Michael Wang; Marilyn J Manco-Johnson; Jorge A Di Paola; Keith B Neeves
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

Review 10.  The impact of blood shear rate on arterial thrombus formation.

Authors:  Kjell S Sakariassen; Lars Orning; Vincent T Turitto
Journal:  Future Sci OA       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.